Bide Pharmaceutical announced that the “Concerted Action Agreement” signed by Dai Lan, the controlling shareholder and actual controller of the company, and Dai Long, has expired and will not be renewed. Dai Lan directly holds 32.4768% of the shares, and Dai Long directly holds 14.4211% of the shares. The employee shareholding platform holds a total of 5.4544% of the shares, and the three hold a total of 52.3523% of the shares. Dai Lan and Dai Long are siblings. After the agreement was terminated, they remained the same actors. The number and ratio of shares did not change, and there were no changes in equity. There were still two controlling shareholders and actual controllers of the company. This termination will not adversely affect the company's operations, etc.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.